Enter assignee name

EPO Patents = 1

Forward Citations = 2

Loading Chart...

9 inventors (with patents filed for the assignee):

Rod L Hartwig (5 out of 5 patents)

James C Oliver (5 out of 7 patents)

Marina Borovinskaya (4 out of 12 patents)

4. Tamanna Lather (4 out of 12 patents)

5. Nisarg Modi (4 out of 14 patents)

6. Fotios M Plakogiannis (4 out of 17 patents)

7. Yuliya C Levintova (2 out of 2 patents)

8. Arturo Serrano-Batista (1 out of 1 patent)

9. Arturo Serrano-Batista (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12390457 - Stable solutions of immunomodulatory imide compounds for parenteral use (2025-08-19),

2. 12383510 - Treatment of vomiting and nausea with minimum dose of olanzapine (2025-08-12),

3. 12201622 - Continuous delivery of lenalidomide and other immunomodulatory agents (2025-01-21),

4. 11975112 - Treatment of vomiting and nausea with minimum dose of olanzapine (2024-05-07),

5. 11197852 - Continuous delivery of lenalidomide and other immunomodulatory agents (2021-12-14),

Starton Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with cancer and other serious diseases. The company leverages its proprietary drug delivery technology to enhance the efficacy and safety of existing therapies, aiming to improve patient outcomes. Starton is committed to advancing its pipeline of product candidates through rigorous clinical trials and collaborations with leading research institutions. With a dedicated team of experts in drug development and a strong focus on patient needs, Starton Therapeutics is poised to make significant contributions to the field of oncology and beyond.

Profile summary based on public USPTO records.